The global Transdermal Patch revenue was US$ 6793 million in 2022 and is forecast to a readjusted size of US$ 8726.9 million by 2029 with a CAGR of 3.6% during the forecast period (2023-2029).

and India Transdermal Patch Market

Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream.Transdermal Patches include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch, oxybutynin transdermal patch, estradiol transdermal patch, nitroglycerin transdermal patch and many others.

In India, the Transdermal Patch revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period (2023-2029).

Transdermal Patches are mainly classified into the following types: Methyl Salicylate-based Patches, Rivastigmine Patches, Fentanyl Patches, Lidocaine Patches, Diclofenac Patches, Nicotine Patches and others. Methyl Salicylate-based segment accounted for the larger part of the revenue market, with 18%, followed by Lidocaine Patches, with 15%.

Transdermal Patches can delivery drugs through Rx Channel or OTC Channel. The former took a larger market share, with its sales volume accounting for about 76% of the total.

Hisamitsu Pharmaceutical, Johnson & Johnson, Nitto Denko and Mylan are the Top 4 players of the global Transdermal Patch market. They took up about 42% of the global market in 2019.

This report focuses on global and India Transdermal Patch market, also covers the segmentation data of other regions in regional level and county level.

India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.

India is a market full of opportunities, and the demand for Transdermal Patch will continue to grow rapidly in the future.

Global Transdermal Patch Scope and Market Size

Transdermal Patch market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global Transdermal Patch market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2018-2029.

For India market, this report focuses on the Transdermal Patch market size by players, by Type and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in India.

Scope of and India Transdermal Patch Market Report

Report Metric	Details
Report Name	and India Transdermal Patch Market
Forecasted market size in 2029	US$ 8726.9 million
CAGR	3.6%
Forecasted years	2023 - 2029
Segment by Type	Methyl Salicylate-based Patch Rivastigmine Transdermal Patch Fentanyl Transdermal Patch Lidocaine Patch Diclofenac Patch Nicotine Transdermal Patch Others
Segment by Application	Rx Channel OTC Channel
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Hisamitsu Pharmaceutical, Johnson & Johnson, Novartis, UCB Pharma, Mylan, Teva Pharmaceutical, Nitto Denko, Grünenthal, IBSA Group, GSK, Luye Pharma Group, Pfizer, Chattem, Dr Reddy’s Laboratories, Bayer, Mundipharma, Endo International, Beijing Tide Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

What is the and India Transdermal Patch Market size in 2029?

Ans: The and India Transdermal Patch Market size in 2029 will be US$ 8726.9 million.

What is the and India Transdermal Patch Market share by region?

Ans: According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment.

Who are the main players in the and India Transdermal Patch Market report?

Ans: The main players in the and India Transdermal Patch Market are Hisamitsu Pharmaceutical, Johnson & Johnson, Novartis, UCB Pharma, Mylan, Teva Pharmaceutical, Nitto Denko, Grünenthal, IBSA Group, GSK, Luye Pharma Group, Pfizer, Chattem, Dr Reddy’s Laboratories, Bayer, Mundipharma, Endo International, Beijing Tide Pharmaceutical

What are the Application segmentation covered in the and India Transdermal Patch Market report?

Ans: The Applications covered in the and India Transdermal Patch Market report are Rx Channel, OTC Channel

What are the Type segmentation covered in the and India Transdermal Patch Market report?

Ans: The Types covered in the and India Transdermal Patch Market report are Methyl Salicylate-based Patch, Rivastigmine Transdermal Patch, Fentanyl Transdermal Patch, Lidocaine Patch, Diclofenac Patch, Nicotine Transdermal Patch, Others

1 Study Coverage

1.1 Transdermal Patch Product Introduction

1.2 Global Transdermal Patch Outlook 2018 VS 2022 VS 2029

1.2.1 Global Transdermal Patch Sales in US$ Million for the Year 2018-2029

1.2.2 Global Transdermal Patch Sales in Volume for the Year 2018-2029

1.3 India Transdermal Patch Outlook 2018 VS 2022 VS 2029

1.3.1 India Transdermal Patch Sales in US$ Million for the Year 2018-2029

1.3.2 India Transdermal Patch Sales in Volume for the Year 2018-2029

1.4 Transdermal Patch Market Size, India VS Global, 2018 VS 2022 VS 2029

1.4.1 The Market Share of India Transdermal Patch in Global, 2018 VS 2022 VS 2029

1.4.2 The Growth Rate of Transdermal Patch Market Size, India VS Global, 2018 VS 2022 VS 2029

1.5 Transdermal Patch Market Dynamics

1.5.1 Transdermal Patch Industry Trends

1.5.2 Transdermal Patch Market Drivers

1.5.3 Transdermal Patch Market Challenges

1.5.4 Transdermal Patch Market Restraints

1.6 Study Objectives

1.7 Years Considered

1.8 Years Considered

2 Transdermal Patch by Type

2.1 Transdermal Patch Market Segment by Type

2.1.1 Methyl Salicylate-based Patch

2.1.2 Rivastigmine Transdermal Patch

2.1.3 Fentanyl Transdermal Patch

2.1.4 Lidocaine Patch

2.1.5 Diclofenac Patch

2.1.6 Nicotine Transdermal Patch

2.1.7 Others

2.2 Global Transdermal Patch Market Size by Type

2.2.1 Global Transdermal Patch Sales in Value, by Type (2018, 2022 & 2029)

2.2.2 Global Transdermal Patch Sales in Volume, by Type (2018, 2022 & 2029)

2.2.3 Global Transdermal Patch Average Selling Price (ASP) by Type (2018, 2022 & 2029)

2.3 India Transdermal Patch Market Size by Type

2.3.1 India Transdermal Patch Sales in Value, by Type (2018, 2022 & 2029)

2.3.2 India Transdermal Patch Sales in Volume, by Type (2018, 2022 & 2029)

2.3.3 India Transdermal Patch Average Selling Price (ASP) by Type (2018, 2022 & 2029)

3 Transdermal Patch by Application

3.1 Transdermal Patch Market Segment by Application

3.1.1 Rx Channel

3.1.2 OTC Channel

3.2 Global Transdermal Patch Market Size by Application

3.2.1 Global Transdermal Patch Sales in Value, by Application (2018, 2022 & 2029)

3.2.2 Global Transdermal Patch Sales in Volume, by Application (2018, 2022 & 2029)

3.3.3 Global Transdermal Patch Average Selling Price (ASP) by Application (2018, 2022 & 2029)

3.3 India Transdermal Patch Market Size by Application

3.3.1 India Transdermal Patch Sales in Value, by Application (2018, 2022 & 2029)

3.3.2 India Transdermal Patch Sales in Volume, by Application (2018, 2022 & 2029)

3.3.3 India Transdermal Patch Average Selling Price (ASP) by Application (2018, 2022 & 2029)

4 Global Transdermal Patch Competitor Landscape by Company

4.1 Global Transdermal Patch Market Size by Company

4.1.1 Global Key Manufacturers of Transdermal Patch, Ranked by Revenue (2022)

4.1.2 Global Transdermal Patch Revenue by Manufacturer (2018-2023)

4.1.3 Global Transdermal Patch Sales by Manufacturer (2018-2023)

4.1.4 Global Transdermal Patch Price by Manufacturer (2018-2023)

4.2 Global Transdermal Patch Concentration Ratio (CR)

4.2.1 Transdermal Patch Market Concentration Ratio (CR)

4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Transdermal Patch in 2022

4.2.3 Global Transdermal Patch Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

4.3 Global Key Manufacturers of Transdermal Patch, Manufacturing Base Distribution and Headquarters

4.4 Global Key Manufacturers of Transdermal Patch, Product Offered and Application

4.5 Global Key Manufacturers of Transdermal Patch, Date of Enter into This Industry

4.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4.7 India Transdermal Patch Market Size by Company

4.7.1 Key Players of Transdermal Patch in India, Ranked by Revenue (2022)

4.7.2 India Transdermal Patch Revenue by Players (2018-2023)

4.7.3 India Transdermal Patch Sales by Players (2018-2023)

5 Global Transdermal Patch Market Size by Region

5.1 Global Transdermal Patch Market Size by Region: 2018 VS 2022 VS 2029

5.2 Global Transdermal Patch Market Size in Volume by Region (2018-2029)

5.2.1 Global Transdermal Patch Sales in Volume by Region: 2018-2023

5.2.2 Global Transdermal Patch Sales in Volume Forecast by Region (2024-2029)

5.3 Global Transdermal Patch Market Size in Value by Region (2018-2029)

5.3.1 Global Transdermal Patch Sales in Value by Region: 2018-2023

5.3.2 Global Transdermal Patch Sales in Value by Region: 2024-2029

6 Americas

6.1 Americas Transdermal Patch Market Size YoY Growth 2018-2029

6.2 Americas Transdermal Patch Sales in Volume, by Type (2018, 2022 & 2029)

6.3 Americas Transdermal Patch Sales in Volume, by Application (2018, 2022 & 2029)

6.4 Americas Transdermal Patch Market Facts & Figures by Country (2018, 2022 & 2029)

6.4.1 Americas Transdermal Patch Sales in Value by Country (2018, 2022 & 2029)

6.4.2 Americas Transdermal Patch Sales in Volume by Country (2018, 2022 & 2029)

6.4.3 United States

6.4.4 Canada

6.4.5 Mexico

6.4.6 Brazil

7 EMEA

7.1 EMEA Transdermal Patch Market Size YoY Growth 2018-2029

7.2 EMEA Transdermal Patch Sales in Volume, by Type (2018, 2022 & 2029)

7.3 EMEA Transdermal Patch Sales in Volume, by Application (2018, 2022 & 2029)

7.4 EMEA Transdermal Patch Market Facts & Figures by Country (2018, 2022 & 2029)

7.4.1 EMEA Transdermal Patch Sales in Value by Country (2018, 2022 & 2029)

7.4.2 EMEA Transdermal Patch Sales in Volume by Country (2018, 2022 & 2029)

7.4.3 Europe

7.4.4 Middle East

7.4.5 Africa

8 China

8.1 China Transdermal Patch Market Size YoY Growth 2018-2029

8.2 China Transdermal Patch Sales in Volume, by Type (2018, 2022 & 2029)

8.3 China Transdermal Patch Sales in Volume, by Application (2018, 2022 & 2029)

9 APAC

9.1 APAC Transdermal Patch Market Size YoY Growth 2018-2029

9.2 APAC Transdermal Patch Sales in Volume, by Type (2018, 2022 & 2029)

9.3 APAC Transdermal Patch Sales in Volume, by Application (2018, 2022 & 2029)

9.4 APAC Transdermal Patch Market Facts & Figures by Region (2018, 2022 & 2029)

9.4.1 APAC Transdermal Patch Sales in Value by Region (2018, 2022 & 2029)

9.4.2 APAC Transdermal Patch Sales in Volume by Region (2018, 2022 & 2029)

9.4.3 Japan

9.4.4 South Korea

9.4.5 China Taiwan

9.4.6 Southeast Asia

9.4.7 India

10 Company Profiles

10.1 Hisamitsu Pharmaceutical

10.1.1 Hisamitsu Pharmaceutical Company Information

10.1.2 Hisamitsu Pharmaceutical Description and Business Overview

10.1.3 Hisamitsu Pharmaceutical Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)

10.1.4 Hisamitsu Pharmaceutical Transdermal Patch Products Offered

10.1.5 Hisamitsu Pharmaceutical Recent Development

10.2 Johnson & Johnson

10.2.1 Johnson & Johnson Company Information

10.2.2 Johnson & Johnson Description and Business Overview

10.2.3 Johnson & Johnson Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)

10.2.4 Johnson & Johnson Transdermal Patch Products Offered

10.2.5 Johnson & Johnson Recent Development

10.3 Novartis

10.3.1 Novartis Company Information

10.3.2 Novartis Description and Business Overview

10.3.3 Novartis Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)

10.3.4 Novartis Transdermal Patch Products Offered

10.3.5 Novartis Recent Development

10.4 UCB Pharma

10.4.1 UCB Pharma Company Information

10.4.2 UCB Pharma Description and Business Overview

10.4.3 UCB Pharma Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)

10.4.4 UCB Pharma Transdermal Patch Products Offered

10.4.5 UCB Pharma Recent Development

10.5 Mylan

10.5.1 Mylan Company Information

10.5.2 Mylan Description and Business Overview

10.5.3 Mylan Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)

10.5.4 Mylan Transdermal Patch Products Offered

10.5.5 Mylan Recent Development

10.6 Teva Pharmaceutical

10.6.1 Teva Pharmaceutical Company Information

10.6.2 Teva Pharmaceutical Description and Business Overview

10.6.3 Teva Pharmaceutical Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)

10.6.4 Teva Pharmaceutical Transdermal Patch Products Offered

10.6.5 Teva Pharmaceutical Recent Development

10.7 Nitto Denko

10.7.1 Nitto Denko Company Information

10.7.2 Nitto Denko Description and Business Overview

10.7.3 Nitto Denko Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)

10.7.4 Nitto Denko Transdermal Patch Products Offered

10.7.5 Nitto Denko Recent Development

10.8 Grünenthal

10.8.1 Grünenthal Company Information

10.8.2 Grünenthal Description and Business Overview

10.8.3 Grünenthal Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)

10.8.4 Grünenthal Transdermal Patch Products Offered

10.8.5 Grünenthal Recent Development

10.9 IBSA Group

10.9.1 IBSA Group Company Information

10.9.2 IBSA Group Description and Business Overview

10.9.3 IBSA Group Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)

10.9.4 IBSA Group Transdermal Patch Products Offered

10.9.5 IBSA Group Recent Development

10.10 GSK

10.10.1 GSK Company Information

10.10.2 GSK Description and Business Overview

10.10.3 GSK Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)

10.10.4 GSK Transdermal Patch Products Offered

10.10.5 GSK Recent Development

10.11 Luye Pharma Group

10.11.1 Luye Pharma Group Company Information

10.11.2 Luye Pharma Group Description and Business Overview

10.11.3 Luye Pharma Group Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)

10.11.4 Luye Pharma Group Transdermal Patch Products Offered

10.11.5 Luye Pharma Group Recent Development

10.12 Pfizer

10.12.1 Pfizer Company Information

10.12.2 Pfizer Description and Business Overview

10.12.3 Pfizer Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)

10.12.4 Pfizer Transdermal Patch Products Offered

10.12.5 Pfizer Recent Development

10.13 Chattem

10.13.1 Chattem Company Information

10.13.2 Chattem Description and Business Overview

10.13.3 Chattem Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)

10.13.4 Chattem Transdermal Patch Products Offered

10.13.5 Chattem Recent Development

10.14 Dr Reddy’s Laboratories

10.14.1 Dr Reddy’s Laboratories Company Information

10.14.2 Dr Reddy’s Laboratories Description and Business Overview

10.14.3 Dr Reddy’s Laboratories Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)

10.14.4 Dr Reddy’s Laboratories Transdermal Patch Products Offered

10.14.5 Dr Reddy’s Laboratories Recent Development

10.15 Bayer

10.15.1 Bayer Company Information

10.15.2 Bayer Description and Business Overview

10.15.3 Bayer Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)

10.15.4 Bayer Transdermal Patch Products Offered

10.15.5 Bayer Recent Development

10.16 Mundipharma

10.16.1 Mundipharma Company Information

10.16.2 Mundipharma Description and Business Overview

10.16.3 Mundipharma Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)

10.16.4 Mundipharma Transdermal Patch Products Offered

10.16.5 Mundipharma Recent Development

10.17 Endo International

10.17.1 Endo International Company Information

10.17.2 Endo International Description and Business Overview

10.17.3 Endo International Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)

10.17.4 Endo International Transdermal Patch Products Offered

10.17.5 Endo International Recent Development

10.18 Beijing Tide Pharmaceutical

10.18.1 Beijing Tide Pharmaceutical Company Information

10.18.2 Beijing Tide Pharmaceutical Description and Business Overview

10.18.3 Beijing Tide Pharmaceutical Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)

10.18.4 Beijing Tide Pharmaceutical Transdermal Patch Products Offered

10.18.5 Beijing Tide Pharmaceutical Recent Development

11 Industry Chain and Sales Channels Analysis

11.1 Transdermal Patch Industry Chain Analysis

11.2 Transdermal Patch Key Raw Materials

11.2.1 Key Raw Materials

11.2.2 Raw Materials Key Suppliers

11.3 Transdermal Patch Production Mode & Process

11.4 Transdermal Patch Sales and Marketing

11.4.1 Transdermal Patch Sales Channels

11.4.2 Transdermal Patch Distributors

11.5 Transdermal Patch Customers

12 Research Findings and Conclusion

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Hisamitsu Pharmaceutical

Dr. Reddy’s Laboratories

Bayer

Mundipharma

Endo International

Beijing Tide Pharmaceutical

List of Tables

Table 1. Transdermal Patch CAGR in Value, India VS Global, 2018 VS 2022 VS 2029

Table 2. Transdermal Patch Market Trends

Table 3. Transdermal Patch Market Drivers

Table 4. Transdermal Patch Market Challenges

Table 5. Transdermal Patch Market Restraints

Table 6. Global Transdermal Patch Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)

Table 7. India Transdermal Patch Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)

Table 8. Global Transdermal Patch Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)

Table 9. India Transdermal Patch Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)

Table 10. Global Key Manufacturers of Transdermal Patch, Ranked by Revenue (2022) & (US$ Million)

Table 11. Global Transdermal Patch Revenue by Manufacturer, (US$ Million), 2018-2023

Table 12. Global Transdermal Patch Revenue Share by Manufacturer, 2018-2023

Table 13. Global Transdermal Patch Sales by Manufacturer, (M Pcs), 2018-2023

Table 14. Global Transdermal Patch Sales Share by Manufacturer, 2018-2023

Table 15. Global Transdermal Patch Price by Manufacturer (2018-2023) & (USD/Pc)

Table 16. Global Transdermal Patch Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 17. Global Transdermal Patch by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transdermal Patch as of 2022)

Table 18. Global Key Manufacturers of Transdermal Patch, Manufacturing Base Distribution and Headquarters

Table 19. Global Key Manufacturers of Transdermal Patch, Product Offered and Application

Table 20. Global Key Manufacturers of Transdermal Patch, Date of Enter into This Industry

Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 22. Key Players of Transdermal Patch in India, Ranked by Revenue (2022) & (US$ million)

Table 23. India Transdermal Patch Revenue by Players, (US$ Million), (2018-2023)

Table 24. India Transdermal Patch Revenue Share by Players, (2018-2023)

Table 25. India Transdermal Patch Sales by Players, (M Pcs), (2018-2023)

Table 26. India Transdermal Patch Sales Share by Players, (2018-2023)

Table 27. Global Transdermal Patch Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 28. Global Transdermal Patch Sales in Volume by Region (2018-2023) & (M Pcs)

Table 29. Global Transdermal Patch Sales in Volume Forecast by Region (2024-2029) & (M Pcs)

Table 30. Global Transdermal Patch Sales in Value by Region (2018-2023) & (US$ Million)

Table 31. Global Transdermal Patch Sales in Value Forecast by Region (2024-2029) & (US$ Million)

Table 32. Americas Transdermal Patch Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 33. Americas Transdermal Patch Sales in Value by Country (2018-2023) & (US$ Million)

Table 34. Americas Transdermal Patch Sales in Value by Country (2024-2029) & (US$ Million)

Table 35. Americas Transdermal Patch Sales in Volume by Country (2018-2023) & (M Pcs)

Table 36. Americas Transdermal Patch Sales in Volume by Country (2024-2029) & (M Pcs)

Table 37. EMEA Transdermal Patch Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 38. EMEA Transdermal Patch Sales in Value by Country (2018-2023) & (US$ Million)

Table 39. EMEA Transdermal Patch Sales in Value by Country (2024-2029) & (US$ Million)

Table 40. EMEA Transdermal Patch Sales in Volume by Country (2018-2023) & (M Pcs)

Table 41. EMEA Transdermal Patch Sales in Volume by Country (2024-2029) & (M Pcs)

Table 42. APAC Transdermal Patch Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 43. APAC Transdermal Patch Sales in Value by Country (2018-2023) & (US$ Million)

Table 44. APAC Transdermal Patch Sales in Value by Country (2024-2029) & (US$ Million)

Table 45. APAC Transdermal Patch Sales in Volume by Country (2018-2023) & (M Pcs)

Table 46. APAC Transdermal Patch Sales in Volume by Country (2024-2029) & (M Pcs)

Table 47. Hisamitsu Pharmaceutical Company Information

Table 48. Hisamitsu Pharmaceutical Description and Business Overview

Table 49. Hisamitsu Pharmaceutical Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2018-2023)

Table 50. Hisamitsu Pharmaceutical Transdermal Patch Product

Table 51. Hisamitsu Pharmaceutical Recent Development

Table 52. Johnson & Johnson Company Information

Table 53. Johnson & Johnson Description and Business Overview

Table 54. Johnson & Johnson Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2018-2023)

Table 55. Johnson & Johnson Transdermal Patch Product

Table 56. Johnson & Johnson Recent Development

Table 57. Novartis Company Information

Table 58. Novartis Description and Business Overview

Table 59. Novartis Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2018-2023)

Table 60. Novartis Transdermal Patch Product

Table 61. Novartis Recent Development

Table 62. UCB Pharma Company Information

Table 63. UCB Pharma Description and Business Overview

Table 64. UCB Pharma Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2018-2023)

Table 65. UCB Pharma Transdermal Patch Product

Table 66. UCB Pharma Recent Development

Table 67. Mylan Company Information

Table 68. Mylan Description and Business Overview

Table 69. Mylan Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2018-2023)

Table 70. Mylan Transdermal Patch Product

Table 71. Mylan Recent Development

Table 72. Teva Pharmaceutical Company Information

Table 73. Teva Pharmaceutical Description and Business Overview

Table 74. Teva Pharmaceutical Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2018-2023)

Table 75. Teva Pharmaceutical Transdermal Patch Product

Table 76. Teva Pharmaceutical Recent Development

Table 77. Nitto Denko Company Information

Table 78. Nitto Denko Description and Business Overview

Table 79. Nitto Denko Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2018-2023)

Table 80. Nitto Denko Transdermal Patch Product

Table 81. Nitto Denko Recent Development

Table 82. Grünenthal Company Information

Table 83. Grünenthal Description and Business Overview

Table 84. Grünenthal Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2018-2023)

Table 85. Grünenthal Transdermal Patch Product

Table 86. Grünenthal Recent Development

Table 87. IBSA Group Company Information

Table 88. IBSA Group Description and Business Overview

Table 89. IBSA Group Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2018-2023)

Table 90. IBSA Group Transdermal Patch Product

Table 91. IBSA Group Recent Development

Table 92. GSK Company Information

Table 93. GSK Description and Business Overview

Table 94. GSK Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2018-2023)

Table 95. GSK Transdermal Patch Product

Table 96. GSK Recent Development

Table 97. Luye Pharma Group Company Information

Table 98. Luye Pharma Group Description and Business Overview

Table 99. Luye Pharma Group Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2018-2023)

Table 100. Luye Pharma Group Transdermal Patch Product

Table 101. Luye Pharma Group Recent Development

Table 102. Pfizer Company Information

Table 103. Pfizer Description and Business Overview

Table 104. Pfizer Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2018-2023)

Table 105. Pfizer Transdermal Patch Product

Table 106. Pfizer Recent Development

Table 107. Chattem Company Information

Table 108. Chattem Description and Business Overview

Table 109. Chattem Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2018-2023)

Table 110. Chattem Transdermal Patch Product

Table 111. Chattem Recent Development

Table 112. Dr Reddy’s Laboratories Company Information

Table 113. Dr Reddy’s Laboratories Description and Business Overview

Table 114. Dr Reddy’s Laboratories Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2018-2023)

Table 115. Dr Reddy’s Laboratories Transdermal Patch Product

Table 116. Dr Reddy’s Laboratories Recent Development

Table 117. Bayer Company Information

Table 118. Bayer Description and Business Overview

Table 119. Bayer Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2018-2023)

Table 120. Bayer Transdermal Patch Product

Table 121. Bayer Recent Development

Table 122. Mundipharma Company Information

Table 123. Mundipharma Description and Business Overview

Table 124. Mundipharma Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2018-2023)

Table 125. Mundipharma Transdermal Patch Product

Table 126. Mundipharma Recent Development

Table 127. Endo International Company Information

Table 128. Endo International Description and Business Overview

Table 129. Endo International Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2018-2023)

Table 130. Endo International Transdermal Patch Product

Table 131. Endo International Recent Development

Table 132. Beijing Tide Pharmaceutical Company Information

Table 133. Beijing Tide Pharmaceutical Description and Business Overview

Table 134. Beijing Tide Pharmaceutical Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2018-2023)

Table 135. Beijing Tide Pharmaceutical Transdermal Patch Product

Table 136. Beijing Tide Pharmaceutical Recent Development

Table 137. Key Raw Materials Lists

Table 138. Raw Materials Key Suppliers Lists

Table 139. Transdermal Patch Customers List

Table 140. Transdermal Patch Distributors List

Table 141. Research Programs/Design for This Report

Table 142. Key Data Information from Secondary Sources

Table 143. Key Data Information from Primary Sources

List of Figures

Figure 1. Transdermal Patch Product Picture

Figure 2. Global Transdermal Patch Revenue, (US$ Million), 2018 VS 2022 VS 2029

Figure 3. Global Transdermal Patch Market Size 2018-2029 (US$ Million)

Figure 4. Global Transdermal Patch Sales 2018-2029 (M Pcs)

Figure 5. India Transdermal Patch Revenue, (US$ Million), 2018 VS 2022 VS 2029

Figure 6. India Transdermal Patch Market Size 2018-2029 (US$ Million)

Figure 7. India Transdermal Patch Sales 2018-2029 (M Pcs)

Figure 8. India Transdermal Patch Market Share in Global, in Value (US$ Million) 2018-2029

Figure 9. India Transdermal Patch Market Share in Global, in Volume (M Pcs) 2018-2029

Figure 10. Transdermal Patch Report Years Considered

Figure 11. Product Picture of Methyl Salicylate-based Patch

Figure 12. Product Picture of Rivastigmine Transdermal Patch

Figure 13. Product Picture of Fentanyl Transdermal Patch

Figure 14. Product Picture of Lidocaine Patch

Figure 15. Product Picture of Diclofenac Patch

Figure 16. Product Picture of Nicotine Transdermal Patch

Figure 17. Product Picture of Others

Figure 18. Global Transdermal Patch Market Share by Type in 2022 & 2029

Figure 19. Global Transdermal Patch Sales in Value by Type (2018-2029) & (US$ Million)

Figure 20. Global Transdermal Patch Sales Market Share in Value by Type (2018-2029)

Figure 21. Global Transdermal Patch Sales by Type (2018-2029) & (M Pcs)

Figure 22. Global Transdermal Patch Sales Market Share in Volume by Type (2018-2029)

Figure 23. Global Transdermal Patch Price by Type (2018-2029) & (USD/Pc)

Figure 24. India Transdermal Patch Market Share by Type in 2022 & 2029

Figure 25. India Transdermal Patch Sales in Value by Type (2018-2029) & (US$ Million)

Figure 26. India Transdermal Patch Sales Market Share in Value by Type (2018-2029)

Figure 27. India Transdermal Patch Sales by Type (2018-2029) & (M Pcs)

Figure 28. India Transdermal Patch Sales Market Share in Volume by Type (2018-2029)

Figure 29. India Transdermal Patch Price by Type (2018-2029) & (USD/Pc)

Figure 30. Product Picture of Rx Channel

Figure 31. Product Picture of OTC Channel

Figure 32. Global Transdermal Patch Market Share by Application in 2022 & 2029

Figure 33. Global Transdermal Patch Sales in Value by Application (2018-2029) & (US$ Million)

Figure 34. Global Transdermal Patch Sales Market Share in Value by Application (2018-2029)

Figure 35. Global Transdermal Patch Sales by Application (2018-2029) & (M Pcs)

Figure 36. Global Transdermal Patch Sales Market Share in Volume by Application (2018-2029)

Figure 37. Global Transdermal Patch Price by Application (2018-2029) & (USD/Pc)

Figure 38. India Transdermal Patch Market Share by Application in 2022 & 2029

Figure 39. India Transdermal Patch Sales in Value by Application (2018-2029) & (US$ Million)

Figure 40. India Transdermal Patch Sales Market Share in Value by Application (2018-2029)

Figure 41. India Transdermal Patch Sales by Application (2018-2029) & (M Pcs)

Figure 42. India Transdermal Patch Sales Market Share in Volume by Application (2018-2029)

Figure 43. India Transdermal Patch Price by Application (2018-2029) & (USD/Pc)

Figure 44. Americas Transdermal Patch Sales in Volume Growth Rate 2018-2029 (M Pcs)

Figure 45. Americas Transdermal Patch Sales in Value Growth Rate 2018-2029 (US$ Million)

Figure 46. Americas Transdermal Patch Sales by Type (2018-2029) & (M Pcs)

Figure 47. Americas Transdermal Patch Sales Market Share in Volume by Type (2018-2029)

Figure 48. Americas Transdermal Patch Sales by Application (2018-2029) & (M Pcs)

Figure 49. Americas Transdermal Patch Sales Market Share in Volume by Application (2018-2029)

Figure 50. United States Transdermal Patch Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 51. Canada Transdermal Patch Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 52. Mexico Transdermal Patch Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 53. Brazil Transdermal Patch Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 54. EMEA Transdermal Patch Sales in Volume Growth Rate 2018-2029 (M Pcs)

Figure 55. EMEA Transdermal Patch Sales in Value Growth Rate 2018-2029 (US$ Million)

Figure 56. EMEA Transdermal Patch Sales by Type (2018-2029) & (M Pcs)

Figure 57. EMEA Transdermal Patch Sales Market Share in Volume by Type (2018-2029)

Figure 58. EMEA Transdermal Patch Sales by Application (2018-2029) & (M Pcs)

Figure 59. EMEA Transdermal Patch Sales Market Share in Volume by Application (2018-2029)

Figure 60. Europe Transdermal Patch Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 61. Middle East Transdermal Patch Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 62. Africa Transdermal Patch Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 63. China Transdermal Patch Sales in Volume Growth Rate 2018-2029 (M Pcs)

Figure 64. China Transdermal Patch Sales in Value Growth Rate 2018-2029 (US$ Million)

Figure 65. China Transdermal Patch Sales by Type (2018-2029) & (M Pcs)

Figure 66. China Transdermal Patch Sales Market Share in Volume by Type (2018-2029)

Figure 67. China Transdermal Patch Sales by Application (2018-2029) & (M Pcs)

Figure 68. China Transdermal Patch Sales Market Share in Volume by Application (2018-2029)

Figure 69. APAC Transdermal Patch Sales in Volume Growth Rate 2018-2029 (M Pcs)

Figure 70. APAC Transdermal Patch Sales in Value Growth Rate 2018-2029 (US$ Million)

Figure 71. APAC Transdermal Patch Sales by Type (2018-2029) & (M Pcs)

Figure 72. APAC Transdermal Patch Sales Market Share in Volume by Type (2018-2029)

Figure 73. APAC Transdermal Patch Sales by Application (2018-2029) & (M Pcs)

Figure 74. APAC Transdermal Patch Sales Market Share in Volume by Application (2018-2029)

Figure 75. Japan Transdermal Patch Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 76. South Korea Transdermal Patch Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 77. China Taiwan Transdermal Patch Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 78. Southeast Asia Transdermal Patch Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 79. India Transdermal Patch Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 80. Transdermal Patch Value Chain

Figure 81. Transdermal Patch Production Process

Figure 82. Channels of Distribution

Figure 83. Distributors Profiles

Figure 84. Bottom-up and Top-down Approaches for This Report

Figure 85. Data Triangulation

Figure 86. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4350

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$6525

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$8700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Long-Acting HIV-1 Inhibitors Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-19B19893

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Methylphenidate Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-30B3636

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Soliris Intravenous Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-3H1702

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mouth Ulcers Drugs Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-13C3384

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions